A phase III trial of cisplatin/etoposide/radiotherapy with or without consolidation docetaxel in patients with inoperable locally advanced stage III non-small cell lung cancer (NSCLC): Hoosier Oncology Group LUN01-24

Trial Profile

A phase III trial of cisplatin/etoposide/radiotherapy with or without consolidation docetaxel in patients with inoperable locally advanced stage III non-small cell lung cancer (NSCLC): Hoosier Oncology Group LUN01-24

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Mar 2016

At a glance

  • Drugs Docetaxel (Primary) ; Cisplatin; Etoposide
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Feb 2016 According to ClinicalTrials.gov record, the treatment table has been amended from 1 arm to 3 arm study and the study design is changed from single to parallel.
    • 09 Dec 2011 Updated survival results published in the Annals of Oncology.
    • 12 May 2009 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top